Aneurysm Coiling & Embolization Devices Market Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis & Forecast: 2025

Market HighlightsThe Global interventional neurology market is expected to grow at an approximate CAGR of 7.8% during forecast period, 2018–2023.Increasing participation of market players is the key factor driving the interventional neurology market.

For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.Various other factors such as technological advancements, presence of a large target patient population, favourable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market.However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7211Regional AnalysisThe Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.In 2017, it was estimated that Europe stood second in the global interventional neurology market.

Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.On the other hand, the Middle East and Africa held least share in the global interventional neurology market due to the low per capita income, especially within the African region.

The burden of neurological disorders in African region has been increasing over the years.

The annual incidence of stroke has been estimated to be 316 per 100 000 in Africa.SegmentationThe Global interventional neurology market is segmented based on disease pathology, product, end user and region.The Global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices.The aneurysm coiling & embolization devices segment is further classified as embolic coils, flow diversion devices, and liquid embolic agents.

The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems.

Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery.

Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.

Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest.

North America dominates the global market, followed by Europe and Japan.

On the basis of product, the neurovascular devices market is classified into four major segments?aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices.

Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.Market Analysis and Insights: Global Neurovascular Devices Market In 2020, the global Neurovascular Devices market size was US$ 175 million and it is expected to reach US$ 254.7 million by the end of 2027, with a CAGR of 5.5% during 2021-2027.

Interventional Neurology Devices And Equipment Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.

The chapter on the impact – both negative and positive – of COVID-19 on the interventional neurology devices and equipment industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.

This includes revised market numbers according to the effects of the coronavirus and the expected interventional neurology devices and equipment market growth numbers 2021-2030.View Complete Report:https://www.thebusinessresearchcompany.com/report/interventional-neurology-devices-and-equipment-global-market-reportThe Interventional Neurology Devices And Equipment Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global interventional neurology devices and equipment market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030.

The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.The Interventional Neurology Devices And Equipment Global Market Report 2021 covers interventional neurology devices and equipment market drivers, interventional neurology devices and equipment market trends, interventional neurology devices and equipment market growth rate, interventional neurology devices and equipment market major players, player-adopted strategies in the market, and interventional neurology devices and equipment market size.The global interventional neurology devices and equipment market is expected to grow from $1.84 billion in 2020 to $2.04 billion in 2021 at a compound annual growth rate (CAGR) of 10.9%.

The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.

The market is expected to reach $2.72 billion in 2025 at a CAGR of 7.5%.Request For The Sample Now:https://www.thebusinessresearchcompany.com/sample.aspx?id=2433=smpThe report covers the interventional neurology devices and equipment market segments-1) By Type: Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support Devices2) By End-User: Hospitals, Neurology Clinics, Ambulatory Care Centers and Others3) Aneurysm Coiling & Embolization Devices By Type: Embolic Coils, Flow Diversion Devices, Liquid Embolic Devices4) Angioplasty Devices By Type: Carotid Artery Stents, Embolic Protection Systems5) Support Devices By Type: Micro Guide Wires, Micro Catheters6) Neurothrombectomy Devices By Type: CLOT Retrieval Devices, Suction And Aspiration Devices, SnaresAbout The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.

Global Neurology Devices Market is anticipated to reach USD 10.8 billion by 2022.

Neurological devices imply “Interventional neurology” is the non-surgical field that uses minimally invasive, image-guided techniques for the treatment of most complex and dangerous diseases of the brain, neck, and spine.The factors that propel the growth of the neurology devices market include increasing demand, rapid urbanization & industrialization, and product development & technological innovation, large patient pool, growing number of private hospitals & diagnostic centers, and awareness among people.

In addition, some of the other factors such as demand for effective neurovascular devices, favorable medical repayment, new product innovation and commercialization, growth in the number of research activities in the field of neurovascular therapies, and improvements in healthcare infrastructure across emerging markets are expected to drive the market further.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/neurology-devices-market/request-sampleOn the other hand, there are factors that may hamper the growth of the market including the high cost of R and complicated government approval processes.

Neurology devices industry is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe.Neurology devices market may be explored by product type, technology, end users, distribution channel, and geography.

The market may be explored by product type as Neurostimulation (Spinal Cord Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, Deep Brain Stimulation, Gastric Electric Stimulation, and Vagus Nerve Stimulation), Aneurysm Coiling & Embolization Devices (Liquid Embolic Agents, Flow Diversion Devices and Embolic Coils), Neurothrombectomy Devices (Snares, Suction and Aspiration Devices and Clot Retrievers), Cerebral Balloon Angioplasty & Stenting Systems (Embolic Protection Systems and Carotid Artery Stents), and Support Devices (Micro guide wires and Micro catheters).The “Neurostimulation devices” segment led the neurology devices industry in 2015 and is anticipated to maintain its dominance by 2022.

The key factors that may attributed to the growth of market include faster acting stimulation devices, aged population, and the development of minimally invasive neurological and the growing number of chronic CNS disorders.Based on technology, the neurology devices market could span Carotid Artery Angioplasty and Stenting, Neurothrombectomy, Embolization and Coiling and Supporting Technologies.

Endovascular coiling is a minimally invasive surgery, there no craniotomy or cutting of bone, no opening of the brain, no retraction of brain or handling of blood vessels, get discharged faster and going back to normal life is fast.

Go through our latest blog of “Neuro Endovascular Coiling” and get to know more about it.

Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growthGrowth in Embolotherapy MarketThe embolotherapy market is projected to reach $4.9 billion by 2024 from $3.3 billion in 2019, at a CAGRof 8.1% from 2019 to 2024.

The growth of the embolotherapy market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario.Product of Embolotherapy MarketMarket is broadly segmented into embolic agents and support devices.

The embolic agents segment is further subsegmented into embolic coils, embolic plug systems, liquid embolic agents, microspheres, and detachable balloons.

The microspheres segment under embolic agents held the largest share of the market in 2018.

The market growth of this segment is majorly driven by the surge in the prevalence of hepatocellular carcinoma (microspheres are widely used to treat this disease), coupled with favorable reimbursement criteria in developed economies.

Moreover, new product launches and approvals are further supporting the growth of this segment.Download PDF Brochure – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185897830Diseases In terms of disease indication, embolotherapy market is classified into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders.

Embolotherapy Market Research report provides a detailed analysis of of main manufactures and geographic regions,global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players.

Embolotherapy Market report includes definitions, classifications, applications, and industry chain structure, development trends, and key regions distributors analysis.The report also provides supply and demand Figures, revenue, revenue and shares.

value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches.Global embolotherapy market is set to witness substantial CAGR of 8.25% in the forecast period of 2019- 2026.

The report contains data of the base year 2018 and historic year 2017.

Increasing application of embolization devices and rising healthcare expenditure are factors for the growth of this market.Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Embolotherapy Market which would mention How the Covid-19 is affecting the Embolotherapy Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Corrugated Board Players to Combat Covid-19 Impact.Get Sample PDF of Embolotherapy Market Report (including COVID19 Impact Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-embolotherapy-marketMarket Drivers and Restraints:Increasing patient preference for minimally invasive procedures will drive the market growthRising funding by government and private organizations will also accelerate the growth of this marketTechnological advancement and development in embolotherapy devices will also propel the market growthFavorable repayment policies for the minimally invasive surgeries is also contributing as a factor for the market growthIncreasing cases of heptocellular cancer and liver cancer will also accelerate the market growthAvailability of therapies in the market will also restrain the growth of this marketStrict regulations for product commercialization will also hamper the market growth Key Players: Global Embolotherapy MarketTerumo Medical Corporation, Merit Medical Systems, Simbionix USA Corporation, Cook, Boston Scientific Corporation, Penumbra, Inc., Meril Life Sciences Pvt.

Ltd., Medtronic, BTG International Ltd, ABK Biomedical Inc., Abbott., AngioDynamics., IMBIOTECHNOLOGIES LTD., Debakey Medlife Private Limited, Heraeus Holding, Guerbet, and others.MAJOR TOC OF THE REPORTChapter One: Embolotherapy Market OverviewChapter Two: Manufacturers ProfilesChapter Three: Global Embolotherapy Market Competition, by PlayersChapter Four: Global Embolotherapy Market Size by RegionsChapter Five: Global Embolotherapy Market Revenue by CountriesChapter Six: Global Embolotherapy Market Revenue by ProductChapter Seven: Global Embolotherapy Market Revenue by  Disease IndicationChapter Eight: Global Embolotherapy Market Revenue by ProcedureChapter Nine: Global Embolotherapy Market Revenue by End- UserChapter Ten: Global Embolotherapy Market Revenue by GeographyGet Detail TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=global-embolotherapy-marketKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the global Embolotherapy MarketAnalysis of market effect factors and their impact on the forecast and outlook of the global Embolotherapy MarketThe detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Embolotherapy MarketA roadmap of growth opportunities available in the Global Embolotherapy Market with the identification of key factorsThe exhaustive analysis of various trends of the Global Embolotherapy Market to help identify market developmentsKey Questions Answered in Report:What is the key to the Embolotherapy Market?What will the Embolotherapy Market Demand and what will be Growth?What are the latest opportunities for Embolotherapy Market in the future?What are the strengths of the key players?Access Full Report @ https://www.databridgemarketresearch.com/reports/global-embolotherapy-marketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.

Transcatheter Embolization and Occlusion Devices Market Research Report by Product (Coiled Devices and Non-Coiled Devices), Indication (Peripheral Vascular Disease, Oncology, Neurology and Urology), End User (Hospitals, Clinics and Ambulatory Surgery Centers) and Region - Forecast till 2027Transcatheter Embolization and Occlusion Devices Market is Expected to Register a Healthy CAGR Over the Forecast Period.

The market held a market value of USD 3,290.4 million in 2018 and is projected to grow at a CAGR of 9.9% during the forecast period.

On the other hand, more expensive products and the presence of a strict regulatory framework for product marketing should limit market growth over the next five years.Transcatheter embolization and occlusion (TEO) are a minimally invasive alternative to open surgery, giving patients preference for minimally invasive surgery as it offers several benefits, including small incisions and minimal tissue pain and surgical scarring, and rapid wound healing.

This can often lead to minor complications and lower operating costs that can help the market growth over the coming years.The technology proves its effectiveness in treating complex interventions.

The embolization technique has become one of the most popular methods of treating various types of cancer, such as kidney, breast, liver (hepatocellular carcinoma), and pancreas.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7864  Segmentation : Transcatheter Embolization And Occlusion (TEO) MarketThe global for transcatheter embolization and occlusion devices market is subdivided into product, indication, end-user, and region.Based on the type, the global market is bifurcated into coiled devices and non-coiled device.

The uncoiled device segment is further subdivided into flow diversion devices, liquid plungers, embolization particles, other embolization, and occlusion devices & accessories.Based on the indications, the market is divided into peripheral vascular diseases, oncology, neurology, urology, and others.Based on the end-user, the market is bifurcated into hospitals and clinics, ambulatory surgery centers (ASCs), and others.Regional Outlook :  Transcatheter Embolization And Occlusion (TEO) MarketBased on the regions, the US is expected to dominate the market over the forecast period due to the availability of medical grants for cardiovascular interventions and large OEMs, allowing for a rapid start of the program, an established health infrastructure, and qualified health professionals.